


| Key | % Net Assets | 
|---|---|
| 7.7% | |
| 6.2% | |
| 5.7% | |
| 5.6% | |
| 74.8% | 
| Name | % Net Assets | 
|---|---|
| GlaxoSmithKline | 7.7% | 
| BG | 6.2% | 
| Royal Dutch Shell ''A'' (UK list) | 5.7% | 
| BP | 5.6% | 
| BT | 5.0% | 
| AstraZeneca | 4.9% | 
| Vodafone | 4.8% | 
| Imperial Tobacco | 4.5% | 
| National Grid | 3.9% | 
| Rolls-Royce | 3.1% | 
No asset data available.
| Date | 20-Aug-2025 | 
|---|---|
| NAV | 321.29p | 
| Currency | GBP | 
| Change | -0.18p | 
| % | -0.06% | 
| YTD change | 39.41p | 
| YTD % | 13.98% | 
| Fund Inception | 12/06/1987 | 
|---|---|
| Fund Manager | Ed Burke | 
| TER | 1.19 (31-Dec-2013) | 
| Minimum Investment | |
|---|---|
| Initial | £500 | 
| Additional | n/a | 
| Savings | £20 | 
| Charges | |
|---|---|
| Initial | 5.00% | 
| Annual Mang't | 1.16% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| No risk data available. | |
You are here: research